Action Cyclacel Pharmaceuticals - CYCC

Cyclacel Pharmaceuticals Inc (CYCC) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

6,365

( - )

Prix Achat

6,21

Prix Vente

6,67

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Cap du marché

35,131M

Clôture Veille

6,365

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

US$ 86 855

Actions en circulation

5 519 456

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-0,36

Bénéfice par action (BPA)

-4,11

Chiffre d'affairess (LTM)

1,53M

Bénéfice net (LTM)

-3,11M

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharma... Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green Med Solution, Inc. was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia. Show more

Secteur

Healthcare

Industrie

Biotechnology & Life Sciences

Site Web

bgmsglobal.com

Siège social

Kuala Lumpur, Malaysia

Fondé

1996

Cyclacel Pharmaceuticals Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker CYCC. Le dernier cours de clôture d'Cyclacel Pharmaceuticals était de US$6,37. Au cours de la dernière année, les actions de Cyclacel Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Cyclacel Pharmaceuticals compte actuellement 5 519 456 actions en circulation. La capitalisation boursière d'Cyclacel Pharmaceuticals est de US$35,13 million. Cyclacel Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.36.

Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

KUALA LUMPUR, Malaysia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (Nasdaq: BGMS, Nasdaq: BGMSP) (“Bio Green Med” or the...

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

KUALA LUMPUR, Malaysia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC...

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

- Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis - KUALA...

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC...

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

- Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and occurs mostly in...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CYCC - Frequently Asked Questions (FAQ)

What is the current Cyclacel Pharmaceuticals Inc share price?

The current share price of Cyclacel Pharmaceuticals Inc is US$ 6,365

How many Cyclacel Pharmaceuticals Inc shares are in issue?

Cyclacel Pharmaceuticals Inc has 5 519 456 shares in issue

What is the market cap of Cyclacel Pharmaceuticals Inc?

The market capitalisation of Cyclacel Pharmaceuticals Inc is USD 35,13M

What is the 1 year trading range for Cyclacel Pharmaceuticals Inc share price?

Cyclacel Pharmaceuticals Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the PE ratio of Cyclacel Pharmaceuticals Inc?

The price to earnings ratio of Cyclacel Pharmaceuticals Inc is -0,36

What is the cash to sales ratio of Cyclacel Pharmaceuticals Inc?

The cash to sales ratio of Cyclacel Pharmaceuticals Inc is 3,8

What is the registered address of Cyclacel Pharmaceuticals Inc?

The registered address for Cyclacel Pharmaceuticals Inc is Level 10, Kuala Lumpur, Wilayah Persekutuan, 592000

What is the Cyclacel Pharmaceuticals Inc website address?

The website address for Cyclacel Pharmaceuticals Inc is bgmsglobal.com

Which industry sector does Cyclacel Pharmaceuticals Inc operate in?

Cyclacel Pharmaceuticals Inc operates in the Biotechnology & Life Sciences sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cyclacel Pharmaceuticals Inc (CYCC)

Cyclacel Pharmaceuticals Inc (CYCC) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Cyclacel Pharmaceuticals Inc

CYCC Dernières nouvelles

Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

Cyclacel Pharmaceuticals Announces Stock Split

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

Cyclacel stock dips after trimming 270% surge amid volatility concerns

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Cyclacel Stock Surges 50% After Amending Exchange Agreement with FITTERS

CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

Cyclacel Pharmaceuticals Announces Stock Split

CYCC - Frequently Asked Questions (FAQ)

CYCC Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Cyclacel Pharmaceuticals Inc (CYCC)

Cyclacel Pharmaceuticals Inc (CYCC) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Cyclacel Pharmaceuticals Inc

CYCC Dernières nouvelles

Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

Cyclacel Pharmaceuticals Announces Stock Split

Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock

CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.

Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB

Cyclacel stock dips after trimming 270% surge amid volatility concerns

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Cyclacel Stock Surges 50% After Amending Exchange Agreement with FITTERS

CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

Cyclacel Pharmaceuticals Announces Stock Split

CYCC - Frequently Asked Questions (FAQ)

CYCC Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS